93 7219 (Topiramate 100 mg)
Pill with imprint 93 7219 is Yellow, Capsule-shape and has been identified as Topiramate 100 mg. It is supplied by Teva Pharmaceuticals USA.
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7219
Topiramate
- Imprint
- 93 7219
- Strength
- 100 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
hypromellose 2910 (15 mPa.s),
polydextrose,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7219 | Teva Pharmaceuticals USA, Inc. |
| 68071-0813 | Nucare Pharmaceuticals Inc. (repackager) |
Related Images for "93 7219"
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1140 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
Consumer resources
- Patient Information
- Topiramate (Advanced Reading)
- Topiramate Tablets
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
- Topiramate Extended-Release Capsules
- Other brands
- Topamax, Trokendi XR, Qudexy XR, Topamax Sprinkle, Topiragen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.